In addition to revealing the promise of CXCR4-targeted 64Cu-CuNCs to be used in TNBC clinical imaging, this study also provided an advantageous method to produce and evaluate the potential of nanoparticles to be applied as cancer theranostics. The gene discussed is CXCR4; the disease is cancer.